Topical steroid withdrawal (TSW) is caused by a physical dependence that develops when topical corticosteroids are used too frequently, at too high a potency, or for too long, typically six months or more. When the steroid is stopped, the skin rebounds with intense redness, burning, and peeling that can be more severe than the original condition. The underlying biology involves changes to how your skin regulates blood flow and responds to inflammation, though the full mechanism is still being studied.
How Skin Becomes Dependent on Steroids
Topical steroids work by suppressing inflammation and constricting blood vessels in the skin. With prolonged use, the body adapts. Cells reduce the number of receptors that respond to the steroid, a process called receptor downregulation. Specifically, the receptor that steroids bind to (called glucocorticoid receptor alpha) decreases in both quantity and sensitivity. Your skin essentially becomes resistant, which is why many people find they need stronger creams over time to get the same effect.
This adaptation creates a cycle: the steroid works less, so you apply it more often or switch to a stronger formulation, which drives further dependence. When you finally stop, your skin has lost its ability to regulate inflammation and blood vessel tone on its own. The result is a rebound reaction where blood vessels dilate uncontrollably, flooding the skin with redness, heat, and swelling. One proposed mechanism for this rebound vasodilation involves nitric oxide, a molecule that widens blood vessels. Researchers have also found elevated levels of a cellular energy molecule called NAD+ in the blood and skin of people experiencing TSW, which may play a role in the oxidative stress driving symptoms.
What Triggers Withdrawal
The trigger itself is straightforward: stopping or significantly reducing topical steroid use after a period of dependence. But several factors determine whether dependence develops in the first place.
- Duration of use: The majority of reported TSW cases involve steroid use lasting six months or longer. The longer the use, the more entrenched the dependence.
- Potency: Mid- to high-potency steroids carry the greatest risk, but TSW has been documented even with the weakest class of steroid, over-the-counter hydrocortisone 1%, when used daily for years.
- Frequency of application: Applying steroids multiple times a day accelerates the dependence cycle.
- Location on the body: The face and genitals absorb steroids more readily than thicker skin on the arms or legs, making these areas especially vulnerable.
- Cosmetic misuse: One common pathway to TSW is using steroid creams for cosmetic purposes, such as skin lightening or treating acne. The papulopustular type of TSW, which features small bumps and pustules rather than widespread redness, most often occurs when steroids have been overused for cosmetic concerns or acne-like conditions.
High-dose topical steroids used for more than a year also carry a risk of suppressing the adrenal glands, the organs that produce your body’s own cortisol. This systemic effect adds another layer of disruption when the steroid is removed.
How Common It Is
Estimates vary enormously depending on how TSW is defined and who is surveyed. A Japanese study found that 12% of patients with atopic dermatitis using topical steroids showed signs of steroid addiction. On the other end, a multinational survey of over 2,100 people with eczema found that 79% of adults and 43% of caregivers reported observing withdrawal-like symptoms. The true prevalence likely falls somewhere in that wide range, and part of the gap reflects the difficulty of separating a genuine withdrawal reaction from a flare of the underlying skin condition.
What TSW Looks and Feels Like
Withdrawal typically begins within 48 hours to three months after stopping topical steroids and unfolds in stages. The first phase is an acute eruption of burning, red, weeping skin. This redness can spread beyond the areas where steroids were originally applied, which is one of the hallmarks that distinguishes it from a simple eczema flare. The skin then enters a dry, intensely itchy phase with significant shedding and peeling. Gradual recovery follows, though the skin remains sensitive and intermittent flares are common. Full recovery to the skin’s baseline state can take weeks to years.
Beyond the general pattern, clinicians look for specific signs that point to TSW rather than a return of eczema. The “headlight sign” describes facial redness that conspicuously spares the nose and upper lip, creating a pattern that looks like headlight beams. The “red sleeve sign” is erythema that wraps around an arm or leg but stops sharply at the wrist or ankle, sparing the palms and soles. Other features include visible spider veins (telangiectasia), skin thinning, reduced elasticity, cracking, swollen lymph nodes, and a rosacea-like appearance on the face.
Burning and stinging tend to dominate in TSW, whereas classic eczema is more purely itchy. The thermal dysregulation is also distinctive: the affected skin radiates heat that you can feel by hovering your hand over it.
How TSW Differs From an Eczema Flare
This distinction matters because the two conditions look similar but require opposite approaches. An eczema flare improves with steroid treatment. TSW is caused by steroid treatment. Misidentifying TSW as worsening eczema and prescribing more steroids deepens the dependence cycle.
Key differences to watch for: TSW symptoms often extend to skin that was never treated with steroids. The burning quality is more prominent than itching. The headlight and red sleeve signs are specific to withdrawal. And the timing is telling: if symptoms worsen dramatically within days of stopping a steroid that previously controlled the condition well, withdrawal is a strong possibility. NIH researchers have provisionally established diagnostic criteria that clinicians can use, including the NAD+ biomarker found in blood and skin samples of people with TSW but not in those without it.
How to Reduce the Risk
There are no formal tapering guidelines specifically for topical steroids, which is part of why TSW catches so many people off guard. General principles from systemic steroid guidelines apply in spirit: if you have been using topical steroids regularly for months, abrupt cessation carries the highest risk of a severe withdrawal reaction. Gradually reducing the potency, frequency, or both gives the skin time to re-adapt.
Some practical strategies that reduce the likelihood of dependence developing in the first place: use the lowest potency steroid that controls your symptoms, apply it for the shortest effective duration, avoid daily use on the face or skin folds whenever possible, and take breaks from treatment rather than using steroids continuously. If you notice that a steroid cream that used to work well now seems ineffective, that loss of response is an early signal that dependence may be forming.